Long-term functional outcomes and patient perspective following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer.
about
Do we reach the patients with the most problems? Baseline data from the WebCan study among survivors of head-and-neck cancer, Denmark.Swallowing therapy and progressive resistance training in head and neck cancer patients undergoing radiotherapy treatment: randomized control trial protocol and preliminary data.The life experience of nutrition impact symptoms during treatment for head and neck cancer patients: a systematic review and meta-synthesis.Development of a chemoradiation therapy toxicity staging system for oropharyngeal carcinoma.Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy.Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.Long-term swallowing after chemoradiotherapy: Prospective study of functional and patient-reported changes over time.The lived experience of dysphagia following non-surgical treatment for head and neck cancer.Third-party disability in carers of people with dysphagia following non-surgical management for head and neck cancer.Carers' experiences of dysphagia in people treated for head and neck cancer: a qualitative study.Reconstructive algorithm and classification system for transoral oropharyngeal defects.Informational Needs of Head and Neck Cancer Patients.Randomized controlled trial of a multisite speech pathology telepractice service providing swallowing and communication intervention to patients with head and neck cancer: Evaluation of service outcomes.Application of the International Classification of Functioning, Disability and Health (ICF) to people with dysphagia following non-surgical head and neck cancer management.
P2860
Q30984056-E834044B-508B-458B-9118-4D36B28CE8D2Q31162460-4F456362-B38D-44B1-8CD6-DEC806D17860Q36282115-2E22FE99-C264-40DE-A5F5-9C9F7BF96EC6Q38267294-3D4260C7-C248-4CD6-94A8-B93FDB8023B6Q38835143-7EC487FC-5CD1-4D3C-85C4-1B663D8C9FB7Q39578584-A1BCACED-1386-4BBF-B36E-B7D60F8906C6Q41643039-9A99713B-8294-4188-97A0-43D72809B20DQ43620228-4A2108CB-EF24-4276-9808-EB36F19E21C6Q48038283-DBC26A0F-2B82-43EF-82A1-9DF8F413B453Q48075935-AF9BD634-25DD-426A-921A-693FC48FBCFDQ51227522-580C4FC6-CB5E-4E79-AAEC-E11410F9B07CQ52732956-D1A9B04A-3321-408C-BF9B-6D2BF6ED1DFBQ52903169-E408CA6F-F098-45D4-90FA-ECF929C30386Q53085927-7530FF14-DE34-4FE4-85A2-AE4DC88CEE93
P2860
Long-term functional outcomes and patient perspective following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Long-term functional outcomes ...... oost for oropharyngeal cancer.
@en
Long-term functional outcomes ...... oost for oropharyngeal cancer.
@nl
type
label
Long-term functional outcomes ...... oost for oropharyngeal cancer.
@en
Long-term functional outcomes ...... oost for oropharyngeal cancer.
@nl
prefLabel
Long-term functional outcomes ...... oost for oropharyngeal cancer.
@en
Long-term functional outcomes ...... oost for oropharyngeal cancer.
@nl
P2093
P2860
P1433
P1476
Long-term functional outcomes ...... boost for oropharyngeal cancer
@en
P2093
Bena Cartmill
Petrea Cornwell
Sandro Porceddu
Wendy Davidson
P2860
P2888
P304
P356
10.1007/S00455-012-9394-0
P577
2012-02-24T00:00:00Z